NasdaqCM - Delayed Quote USD
Vistagen Therapeutics, Inc. (VTGN)
2.3150
-0.0450
(-1.91%)
At close: June 12 at 4:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ADLER REID G. General Counsel | Stock Award(Grant) | Jun 28, 2024 | 16,509 |
| ANDERSON CYNTHIA LYNN Chief Financial Officer | Stock Award(Grant) | Dec 31, 2024 | 6,184 |
| COMMODORE CAPITAL LP Beneficial Owner of more than 10% of a Class of Security | Purchase | Aug 7, 2023 | -- |
| DOTSON JERROLD DUANE Chief Financial Officer | Stock Award(Grant) | Jun 30, 2023 | 3,671 |
| PRINCE JOSHUA Chief Operating Officer | Stock Award(Grant) | Dec 31, 2024 | 5,981 |
| SINGH SHAWN K Chief Executive Officer | Stock Award(Grant) | Jun 28, 2024 | 31,362 |
Related Tickers
GRCE Grace Therapeutics, Inc.
2.9200
+2.46%
MIST Milestone Pharmaceuticals Inc.
1.6800
-2.33%
LPCN Lipocine Inc.
3.1600
-4.24%
SKYE Skye Bioscience, Inc.
2.1700
0.00%
VTVT vTv Therapeutics Inc.
16.00
-3.26%
APLT Applied Therapeutics, Inc.
0.3650
-1.83%
MURA Mural Oncology plc
2.5300
-1.17%
VSTM Verastem, Inc.
5.88
-1.51%
TRVI Trevi Therapeutics, Inc.
6.17
-1.28%
ANNX Annexon, Inc.
2.7100
+7.54%